Leading Connected Drug Delivery Devices Country Markets Databank
The Connected Drug Delivery Devices market was valued at $319.0 Million in 2020, and is projected to reach $743.8 Million by 2029 growing at a CAGR of 9.92% from 2021 to 2029. Asia-Pacific is expected to be the highest contributor to this market, with $128.9 Million in 2020, and is anticipated to reach $345.7 Million by 2029, registering a CAGR of 11.63%. Asia-Pacific and Europe collectively expected to account for about 67.7% share of the Connected Drug Delivery Devices market in 2020, with the former constituting around 40.4% share. Asia-Pacific and North America are expected to witness significant growth rates at a CAGR of 11.63% and 10.15% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 65.0% in the overall Connected Drug Delivery Devices market in 2020, and is anticipated to reach 71.6% by 2029.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook